Noopept Spray

Noopept is a synthetic nootropic dipeptide ethyl ester developed in Russia as a cognitive-enhancing agent with putative neuroprotective properties. It is rapidly hydrolyzed in vivo to cycloprolylglycine, a naturally occurring brain dipeptide that modulates AMPA receptor sensitivity and long-term potentiation. Research has documented increased expression of NGF and BDNF in hippocampal tissue, along with antioxidant and anti-inflammatory activity relevant to neurodegeneration models. The intranasal atomizer formulation is designed to bypass first-pass hepatic metabolism, potentially enabling rapid CNS delivery for acute and subchronic cognitive research studies.

Molecular Information

CAS Number	157115-85-0
Molecular Formula	C₁₇H₂₂N₂O₄
Molecular Weight	318.37 g/mol
Purity	≥98% (HPLC)
Appearance	Lyophilized white powder / clear solution
Delivery Format	Intranasal atomizer spray

Quality Assurance & Supplier Commitment

We maintain longstanding relationships with leading peptide lyophilizers and raw material suppliers, selected through an exhaustive vetting process that evaluates manufacturing practices, analytical capabilities, and regulatory compliance. Our API sourcing protocol includes certificate of analysis review, third-party analytical testing, and periodic supplier audits to ensure consistent purity, potency, and sterility standards across all product lines.

Each batch undergoes meticulous quality control verification prior to release, including HPLC purity analysis, mass spectrometry confirmation, and endotoxin testing where applicable. Our commitment to sourcing integrity ensures researchers receive material of the highest available quality.